Drugs with this side effect
- 2-hydroxysuccinaldehyde: 10% - 16.2%
- 5-ASA: very rare, postmarketing, 1.1% - 17%
- 5-aza-2'-deoxycytidine: 9.88% - 20.5%
- 5-azacytidine: very common, 3.26% - 22.3%
- 6-mercaptopurine
- ALX 111
- AMD3100: common, 0% - 13%
- BPTI
- Benicar-HCT
- CAS 76095-16-4
- CAS 76420-72-9: postmarketing
- CGP 19835A: very common, 10%
- Cancidas
- Carfilzomib: 0% - 15.8%
- Colimycin M
- D-penicillamine
- EDTA
- Enfuvirtide
- FAMP
- FK463
- Fe(III: postmarketing, 1.4% - 4.3%
- Forteo: uncommon, 10.1%
- Gd-DTPA
- Ge-132: 7%
- Glat copolymer
- Goserelin: 1-10%
- Histrelin
- ICI 182,780: 7.75% - 8.03%
- Implanon: postmarketing
- Insulin: 0.921% - 6.3%
- K779: 3% - 34%
- Kaluril
- L-Dmp: frequent
- LY146032: postmarketing, uncommon, 0% - 11.2%
- Lantus: 14.2% - 16.1%
- Leuprorelin
- LiOH
- Lisinopril: postmarketing
- Lovaza
- MDV3100: 2.5% - 20.5%
- Metrodin
- Nafarelin
- NovoLog
- Octreotide: 1.67% - 4.4%
- Oestrogen: common, 1% - 14%
- Optison: rare
- PCI-32765: 0% - 17%
- PGE2
- Photofrin: 1.01% - 8.7%
- SOM230: 6.1% - 10%
- SU5416: 26%
- Saxagliptin
- Signifor: 6.1% - 10%
- Supremon: 4.76%
- Symlin
- TMC207: 32.9%
- Triptorelin: 0.8% - 7.5%
- UDCA: 7.7% - 7.74%
- VACV: 0% - 6%
- Zyprexa Relprevv: common
- abacavir
- abacavir-lamivudine: postmarketing
- acamprosate
- acebutolol: 1% - 3%
- acipimox
- acitretin: postmarketing
- acyclovir
- alfuzosin: 1.4%
- aliskiren: common
- allopurinol
- almotriptan: postmarketing, rare
- alprazolam: 2.4%
- ambrisentan: 0.769% - 2.99%
- amikacin
- amiloride
- amlodipine
- amlodipine besylate
- amphotericin B
- anagrelide: 1-5%
- anastrozole: 0.0001% - 35.9%
- anthracycline: 0% - 7%
- apomorphine
- aprepitant
- aripiprazole: 1% - 5%
- arsenic
- arsenic trioxide: common
- articaine
- asenapine: 3%
- atazanavir: postmarketing, uncommon
- atomoxetine
- atorvastatin: 0% - 6.9%
- avanafil
- axitinib: 1% - 15%
- azathioprine
- azithromycin: postmarketing, 0% - 4.2%
- balsalazide: 2.4% - 4%
- benazepril
- benazeprilat
- bendamustine: 0%
- benzathine penicillin
- betaxolol: 0% - 5.2%
- bexarotene: common, 10%
- bisoprolol: 2.2% - 4.2%
- boceprevir: very common, 14% - 19%
- bortezomib: 0% - 26.3%
- bosentan: 7% - 9%
- bosutinib: 0%
- brimonidine
- brinzolamide: postmarketing
- bromcresol green: 0% - 3%
- budesonide: 1.96% - 5%
- bupivacaine
- buprenorphine: 2%
- bupropion: postmarketing, 0.5% - 5%
- buspirone: infrequent
- busulfan
- cabazitaxel: 1%
- cabergoline: 0% - 6.7%
- cabozantinib: 0% - 14%
- candesartan
- candesartan cilexetil
- capecitabine: 1% - 24%
- captopril: postmarketing
- carbamazepine: very rare, rare
- carbimazole
- carboplatin
- carvedilol: 1% - 6.4%
- cefaclor
- cefadroxil
- cefditoren: postmarketing
- cefuroxime
- cefuroxime axetil
- celecoxib: 3% - 7%
- cephalexin
- cerivastatin: 4.3%
- cetirizine
- cevimeline: 3.7%
- chlorhexidine
- ciclesonide: 0.9% - 3.5%
- cidofovir
- cilazapril
- cilostazol
- cimetidine
- cinacalcet: 5.88% - 17.2%
- ciprofloxacin: postmarketing, uncommon
- citalopram: infrequent, frequent, 1.8% - 2%
- cladribine: common, 3% - 5%
- clofarabine: common
- clomiphene citrate: postmarketing
- clomipramine: 3%
- clonazepam
- clonidine
- clopidogrel: very rare, postmarketing
- clozapine
- colchicine
- colestimide: uncommon
- colestipol
- colestyramine
- conjugated estrogens: postmarketing
- copolymer 1
- cyclophosphamide: postmarketing
- cytarabine: 9.09% - 14.3%
- dabigatran etexilate
- dabrafenib: very common, 0% - 44%
- danazol
- darifenacin
- darunavir
- dasatinib: common, 0% - 12%
- deferasirox
- deferiprone
- deferoxamine: very common
- degarelix: 4% - 9%
- delamanid
- delavirdine
- demethyl
- deprenyl: infrequent
- dexamethasone sodium phosphate
- diazepam
- diclofenac: 0% - 40.4%
- dicloxacillin
- didanosine: postmarketing
- dihydroergotamine: rare
- diltiazem: 1.44%
- dipyridamole: 0.3%
- docetaxel: 0% - 39.7%
- dofetilide
- dolasetron
- donepezil: infrequent
- dorzolamide
- doxazosin: 0% - 1.3%
- doxepin: infrequent
- doxercalciferol: 4.9%
- doxorubicin: common
- doxycycline: 5.63%
- doxycycline hyclate: 5.63%
- duloxetine
- efavirenz: postmarketing
- eicosapentaenoic acid
- eletriptan: infrequent
- eliglustat: 45%
- eltrombopag: 12%
- empagliflozin: 2.3% - 2.4%
- emtricitabine
- eplerenone
- eprosartan: 2%
- eribulin: 1% - 22%
- erlotinib: 1% - 14%
- ertapenem
- esomeprazole magnesium
- estazolam: rare
- estradiol: postmarketing, 0% - 12.4%
- estradiol cypionate
- estrone
- ethambutol
- etidronate: postmarketing
- etodolac
- etoricoxib
- everolimus: common, 0% - 15%
- exemestane: very common, 8.6% - 28.8%
- exenatide: 0% - 4.82%
- ezetimibe: postmarketing, 0.3% - 4.3%
- famciclovir: very rare, postmarketing
- famotidine
- febuxostat: 0.7% - 1.1%
- felbamate
- felodipine
- fenofibrate: postmarketing, 1.9% - 4.9%
- fenofibric acid: postmarketing, 3.48% - 4.9%
- fentanyl: 0% - 8.33%
- ferumoxytol: postmarketing
- flecainide
- flucloxacillin: very rare
- fludarabine: 0% - 1%
- fluocinolone acetonide
- fluoxetine
- flurazepam
- fluticasone
- fluticasone/salmeterol: common
- fluvastatin: postmarketing, 0.2% - 4.1%
- fluvoxamine: infrequent, uncommon
- formoterol
- foscarnet
- fosinopril
- fosinoprilat
- fosphenytoin: infrequent
- frovatriptan: infrequent
- gabapentin: infrequent, frequent
- gadobenate dimeglumine
- gadodiamide
- gadolinium
- gadopentetate: postmarketing
- gadoversetamide
- galantamine
- ganciclovir: 1.7% - 2.4%
- gatifloxacin
- gemcitabine: 0% - 22%
- gemfibrozil
- gemifloxacin
- gentamicin
- glibenclamide
- gliclazide: 3% - 3.5%
- glipizide
- glutamine: 0% - 43.8%
- gold sodium thiomalate
- granisetron
- guanfacine: postmarketing
- halofantrine
- hepatitis B vaccines: rare
- histamine
- hydralazine: common
- hydrochlorothiazide
- hydrocodone
- hydromorphone: 2.01% - 5.97%
- hydroxybutyrate: postmarketing
- ibandronate: 3.5% - 10%
- ibuprofen
- icodextrin: postmarketing
- ifosfamide: postmarketing
- iloperidone: 3%
- imatinib: very common, 0% - 40%
- imiquimod: postmarketing, uncommon, common, 0% - 2.5%
- indapamide
- indinavir: postmarketing
- insulin detemir: 1.9%
- iodide
- iodixanol
- iohexol
- iopromide
- ioxaglate
- irbesartan: postmarketing
- irbesartan-hydrochlorothiazide
- iron sucrose: 7.7%
- isomannide
- isosorbide-5-mononitrate
- isradipine: very rare
- itraconazole: postmarketing
- ivacaftor: 5%
- ivermectin: 1%
- ixabepilone: 5% - 49%
- ketoconazole: postmarketing
- ketorolac tromethamine
- lamivudine: common, 5%
- lamotrigine: 2% - 2.9%
- lanreotide
- lansoprazole
- lapatinib: very common
- latanoprost
- leflunomide: 0% - 9%
- lenalidomide: postmarketing, common, 1.49% - 8.21%
- lercanidipine
- letrozole: very common, 0.975% - 25.2%
- leuprorelin acetate: 6.4% - 18.4%
- levetiracetam: 2%
- linagliptin
- lithium
- lithium carbonate
- lomefloxacin
- lomitapide
- losartan
- lovastatin: postmarketing
- mannitol
- medroxyprogesterone: 1%
- medroxyprogesterone acetate: postmarketing, 1-5%
- mefloquine: postmarketing
- melatonin
- meloxicam: 0% - 5.3%
- memantine: 2.58%
- mesna
- methimazole
- methotrexate
- methyldopa
- methylphenidate: postmarketing, common
- methylprednisolone
- methylprednisolone sodium succinate
- methysergide
- metolazone: 3.1%
- metoprolol: very rare, postmarketing, common
- metronidazole
- mexiletine: 1.4% - 5.1%
- mianserin
- mifepristone: 30%
- minocycline: 0.8% - 1.34%
- mipomersen
- mirabegron: 1.3% - 2.1%
- mirtazapine: postmarketing, frequent
- misoprostol: postmarketing
- mitoxantrone: 5%
- modafinil
- moexiprilat
- mometasone
- mometasone furoate
- montelukast: postmarketing
- morphine
- moxifloxacin
- mycophenolate mofetil
- mycophenolic acid: 7% - 13.8%
- nabilone
- nafcillin
- nalidixic acid
- nalmefene
- naltrexone
- naproxen
- naratriptan: infrequent
- nefazodone
- nelarabine: 0% - 9%
- nelfinavir
- neostigmine: postmarketing
- nevirapine: postmarketing, uncommon, 2%
- niacin
- nicardipine
- nicotine: 5%
- nifedipine: postmarketing
- nilotinib: 0% - 9%
- nisoldipine
- norfloxacin: postmarketing
- ofatumumab: 0% - 3%
- ofloxacin
- ogen
- olanzapine: uncommon, common, 2% - 5%
- olmesartan: 0% - 1.97%
- olmesartan medoxomil
- olodaterol: 2.05%
- olsalazine: 4%
- omeprazole: postmarketing, rare
- oseltamivir
- oxacillin
- oxaliplatin: very common, 7% - 10%
- oxcarbazepine: very rare, postmarketing
- oxprenolol
- oxybutynin: 1.5% - 2%
- oxycodone
- paclitaxel: rare, very common, 1% - 2%
- paliperidone
- palonosetron
- pamidronate: common, 10.7% - 15.3%
- pantoprazole: postmarketing, rare, 1.4% - 2.8%
- parecoxib
- paricalcitol: 4.8%
- paroxetine: rare, infrequent, uncommon, frequent, 2%
- pazopanib
- pemetrexed: 0% - 13%
- penicillin
- pentamidine
- pentosan polysulfate: 0%
- pentostatin: 3% - 14%
- perampanel: 0% - 3%
- pergolide: frequent, 1.6%
- perindopril
- perindopril erbumine: postmarketing
- perindoprilat: postmarketing
- phenytoin: infrequent
- phosphate
- pilocarpine
- pimecrolimus: 0% - 1.52%
- pindolol: 4% - 7%
- pioglitazone: 3.1% - 5.4%
- piperacillin: rare
- pirfenidone
- pitavastatin
- pixantrone
- pomalidomide: 15.2% - 15.9%
- ponatinib: 0% - 31%
- posaconazole
- pramipexole: 1.9%
- pravastatin: postmarketing, 5.9% - 6%
- prazosin
- prednisolone phosphate
- prednisone
- pregabalin: frequent, 4%
- primidone
- procainamide
- procaine penicillin
- procarbazine
- progesterone: postmarketing, 22%
- propylthiouracil
- prostacyclin: 65% - 84%
- pyrazinamide
- quetiapine: infrequent, 1% - 4%
- quinapril
- quinaprilat
- quinidine
- rabeprazole: postmarketing
- raloxifene: 10.7% - 15.5%
- raltegravir
- raltitrexed: 2%
- ramelteon: 2%
- ramipril
- ramiprilat
- ranitidine
- rapamycin: very common, 13% - 31%
- rasagiline: common, 5% - 8%
- rasburicase
- regadenoson: uncommon
- repaglinide: 3% - 4%
- retinoic acid: postmarketing, 20-30%
- ribavirin: very common, 15% - 33%
- rifabutin
- rifapentine
- rifaximin: 6.43%
- riluzole: 1.6% - 5.1%
- risedronate: 5.5% - 32.8%
- risperidone: frequent, 1.5% - 4%
- ritonavir: 0% - 1.7%
- rivastigmine: infrequent, frequent
- rizatriptan
- rofecoxib
- ropinirole: 4% - 7%
- ropivacaine: 0.5% - 1.6%
- rosiglitazone: 4.2% - 5%
- rosuvastatin: very rare, postmarketing, 3.8% - 10.1%
- rotigotine: 11%
- salbutamol: postmarketing
- salmeterol: very rare
- salmon calcitonin acetate: postmarketing, common, 3.8% - 5.3%
- saquinavir
- sertraline: postmarketing, infrequent, uncommon
- sevelamer: 3%
- sevelamer hydrochloride: 12.1% - 17.8%
- sibutramine
- sildenafil
- simvastatin: postmarketing, 0.1%
- sitagliptin: postmarketing
- sodium cromoglycate
- sodium ferric gluconate
- sodium thiosulfate
- sofosbuvir: common, very common
- sorafenib: postmarketing, very common
- sparfloxacin
- stavudine: uncommon
- strontium ranelate: postmarketing
- sulfadiazine
- sulfamethoxazole
- sulfasalazine
- sulindac
- sumatriptan
- sunitinib
- tacrolimus: common, 0% - 25%
- tadalafil
- tamoxifen: 11.1% - 15.1%
- tamsulosin: 3%
- tapentadol: 1%
- teduglutide
- telavancin: uncommon
- telithromycin: postmarketing
- telmisartan: rare, common
- temozolomide: common, 0% - 6.25%
- temsirolimus
- tenofovir
- tenofovir disoproxil fumarate
- terazosin
- terbinafine: postmarketing, very common
- terconazole: postmarketing
- tesamorelin: 13.3%
- testosterone: postmarketing
- testosterone enanthate: postmarketing
- testosterone propionate
- testosterone undecanoate
- tetracycline
- tetraen
- tetrahydrobiopterin
- thalidomide: 0% - 12.7%
- thiotepa
- thymidine: 1% - 4.46%
- thyroxine
- tiagabine: frequent
- tibolone
- ticlopidine
- tiludronate
- timolol: postmarketing
- tinidazole
- tiopronin
- tiotropium
- tizanidine: postmarketing, infrequent
- tofacitinib
- tolcapone
- tolterodine
- topiramate: postmarketing, frequent, 1% - 7%
- topotecan: 0.2% - 3%
- torasemide: 1.8%
- trabectedin
- tramadol: 0.9% - 5.36%
- trametinib: 0% - 44%
- trandolapril
- tranexamic acid: 6.9%
- travoprost
- trazodone
- treprostinil
- trimethoprim: very rare
- trimethoprim-sulfamethoxazole: very rare
- trovafloxacin
- umeclidinium: 2%
- ustekinumab: common
- v 1784: postmarketing, 1.1% - 6%
- valdecoxib
- valganciclovir: 6% - 7%
- valproate
- valsartan: 1.3% - 3%
- vandetanib
- vardenafil
- varenicline: frequent
- vemurafenib: postmarketing, 1% - 67%
- venlafaxine: frequent
- verapamil: postmarketing
- verteporfin
- vigabatrin: very common, 5% - 10%
- vilazodone: 3%
- vildagliptin: uncommon
- vinflunine
- vinorelbine: postmarketing, 0% - 3%
- vismodegib: 0.7% - 15.9%
- voriconazole
- zafirlukast
- zalcitabine
- zaleplon: frequent
- zanamivir: 2%
- ziconotide
- zidovudine
- zidovudine/lamivudine: postmarketing
- zileuton
- ziprasidone
- zoledronic acid: postmarketing, common, very common, 3% - 27.3%
- zolmitriptan: infrequent
- zolpidem: frequent, 2% - 4%
- zonisamide: infrequent
|
Drugs with this indication
|
